Navigation Links
Fampridine in Medical News

Drug Improves Mobility in Some MS Patients

... fampridine may boost walking ability, but some risks tied to ... FRIDAY, Feb. 27 (HealthDay News) -- The drug fampridine improves walking ability in some people with multi...ndomly assigned to receive either 10 milligrams of fampridine or a placebo twice a day for 14 weeks. The patient...
Fampridine in Medical Technology

Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting

...istory of seizures, having previous treatment with fampridine or having an MS exacerbation within 60 days of scr...ase tablet formulation of the investigational drug fampridine (4-aminopyridine, or 4-AP). Data collected in laboratory studies found that fampridine can improve the communication between damaged nerv...

Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting

...ne-SR is a sustained-release tablet formulation of the investigational drug fampridine (4-aminopyridine, or 4-AP). Data collected in laboratory studies found that fampridine can improve the communication between damaged nerves, which may result in i...
Fampridine in other areas

Acorda :: Pipeline :: Clinical :: Fampridine - SR:MS

In laboratory studies fampridine has been found to improve impulse conduction in ... To learn about Fampridine-SR's mechanism of action click here. ...

Acorda :: Pipeline :: Clinical :: Fampridine - SR:MS

Fampridine-SR's major action is to block specialized potassium channels on axons. ... closing the exposed potassium channels, Fampridine-SR permits the axon to ...

Fampridine-SR – Treatment for Multiple Sclerosis - Drug Development ...

News and project information on the Tysabri (natalizumab) is a humanised therapeutic monoclonal antibody. ... Industry Projects • Fampridine-SR – Treatment for ...

Experimental MS Drug Fampridine May Aid Walking on RxList

Learn more about the experimental drug fampridine and how it may improve walking and coordination in people with multiple sclerosis.

MSRC: MS Research News : Drugs : Fampridine-SR

The home site of the Multiple Sclerosis Resource Centre, Multiple Sclerosis, Multiple Sclerosis Resource Centre, MSRC, Telephone Counselling Service, 24hour, MS, ...

Fampridine-SR

This pill -- Fampridine-SR -- may make life a little easier for people with MS. ... Fampridine bridges the gap and allows nerve messages to get across. ...
Other Tags
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District ... against C.R. Bard, Inc. in that proceeding’s first bellwether trial. ... defense request for a new trial after finding that C.R. ...
(Date:1/22/2015)... 2015 A new white paper by ... person-centeredness in the long-term care environment as well as ... continuum. The paper, “The Power of Person-Centeredness in Long-Term ... practices of the patient, resident and family experience in ...
(Date:1/22/2015)... January 22, 2015 Autocarinsurancebest.com has released a ... a commercial auto insurance policy . , Auto insurance ... vehicles. It is no longer necessary to call an agent ... now available online on a single website: http://autocarinsurancebest.com/ . ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting ... . , Purchasing an accidental death and dismemberment rider ... type of rider provides benefits if the insured dies in ... lesser form of life insurance. , AD&D is not ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
(Date:1/22/2015)... , January 22, 2015 , ... year  The European Patent Office to present a video ... British nominations to be featured: Christofer Toumazou and ... former finalists and winners of the Award   Starting ...
(Date:1/22/2015)... , Jan. 22, 2015   EyeLock, Inc. , a ... has appointed Steve Gerber to the new role ... be responsible for leading development of mobile platforms and wearable ... of success and innovation in the semiconductor industry to his ...
(Date:12/24/2014)...  Since its launch in December 2014, the 1U™ ... of trying to remember their usernames and passwords through replacing ... smartphones. To assist people who have struggled to remember usernames ... 1U and focuses on redefining identity, announced today that it ...
Breaking Biology News(10 mins):Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3
Other Contents